Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Untch

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|March 15, 1996
Comparative analyses of bone marrow micrometastases in breast and gastric cancerI Funke, S Fries, M Rolle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancerO Camara, M Rengsberger, A Egbe, et al.
Breast Cancer Research and Treatment|September 20, 2001
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samplesG Konecny, M Untch, D Slamon, et al.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
British Journal of Cancer|April 16, 2002
Serum CEA and CA 15-3 as prognostic factors in primary breast cancerF G Ebeling, P Stieber, M Untch, et al.
Breast Cancer Research and Treatment|January 5, 2002
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancerG Konecny, M Fritz, M Untch, et al.
International Journal of Cancer|March 10, 2001
Nucleosomes in serum of patients with benign and malignant diseasesS Holdenrieder, P Stieber, H Bodenmüller, et al.
Oncology|November 1, 1994
Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancerM Hunz, A Jetter, M Warm, et al.
HNO|June 20, 2013
[The EXIT procedure]S Lehmann, A Blödow, W Flügel, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|March 15, 1996
Comparative analyses of bone marrow micrometastases in breast and gastric cancerI Funke, S Fries, M Rolle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancerO Camara, M Rengsberger, A Egbe, et al.
Breast Cancer Research and Treatment|September 20, 2001
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samplesG Konecny, M Untch, D Slamon, et al.
Gynecologic Oncology|April 1, 1994
Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assayM Untch, B U Sevin, J P Perras, et al.
British Journal of Cancer|April 16, 2002
Serum CEA and CA 15-3 as prognostic factors in primary breast cancerF G Ebeling, P Stieber, M Untch, et al.
Breast Cancer Research and Treatment|January 5, 2002
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancerG Konecny, M Fritz, M Untch, et al.
International Journal of Cancer|March 10, 2001
Nucleosomes in serum of patients with benign and malignant diseasesS Holdenrieder, P Stieber, H Bodenmüller, et al.
Oncology|November 1, 1994
Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancerM Hunz, A Jetter, M Warm, et al.
HNO|June 20, 2013
[The EXIT procedure]S Lehmann, A Blödow, W Flügel, et al.
Pageof 17